Literature DB >> 8102746

Negligible excretion of 5-aminosalicylic acid in breast milk.

U Klotz, A Harings-Kaim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8102746     DOI： 10.1016/0140-6736(93)91443-p

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Is mesalazine really safe for use in breastfeeding mothers?

Authors:  D A Silverman; J Ford; I Shaw; C S J Probert
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 2.  IBD: reproductive health, pregnancy and lactation.

Authors:  Philip Hendy; Georgina Chadwick; Ailsa Hart
Journal:  Frontline Gastroenterol       Date:  2014-04-15

Review 3.  Pharmacokinetic considerations in the treatment of inflammatory bowel disease.

Authors:  M Schwab; U Klotz
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  Treating inflammatory bowel disease during pregnancy: risks and safety of drug therapy.

Authors:  W Connell; A Miller
Journal:  Drug Saf       Date:  1999-10       Impact factor: 5.606

Review 5.  From conception to delivery: managing the pregnant inflammatory bowel disease patient.

Authors:  Vivian W Huang; Flavio M Habal
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.